RecruitingNot applicableNCT07573059
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated Patients
Studying Disorder of branched-chain amino acid metabolism
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Immedica Pharma US Inc
- Principal Investigator
- Mattias Rudebeck, PhDImmedica Pharma US Inc
- Intervention
- Loargys Arginine Test System(device)
- Enrollment
- 100 enrolled
- Eligibility
- 0-100 years · All sexes
- Timeline
- 2026 – 2027
Study locations (1)
- Rare Disease Research, Atlanta, Georgia, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07573059 on ClinicalTrials.govOther trials for Disorder of branched-chain amino acid metabolism
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNANCT06953505At Home Ammonia Monitoring of Inborn Errors of Ammonia MetabolismSequitur Health Corp.
- RECRUITINGNCT05040178An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and PediatricsRECORDATI GROUP
- RECRUITINGPHASE1, PHASE2NCT05130437A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 StudyModernaTX, Inc.
- RECRUITINGPHASE1, PHASE2NCT04159103Open-Label Study of mRNA-3927 in Participants With Propionic AcidemiaModernaTX, Inc.
- RECRUITINGNCT04176523Understanding the Long-Term Management of Organic Acidemia Patients With CARBAGLU®: A Mixed Methods ApproachRECORDATI GROUP
- RECRUITINGNCT02890342Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic AcidemiaNational Human Genome Research Institute (NHGRI)
See all trials for Disorder of branched-chain amino acid metabolism →